Table of Contents Table of Contents
Previous Page  478 / 1674 Next Page
Information
Show Menu
Previous Page 478 / 1674 Next Page
Page Background

Impacto de SI & Grade invasivo

Grade 3

Grade 1-2

EORTC 22881/10882 trial; various articles

Risk factors: after lumpect. + WBRT +/- boost